Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | BIOA | ANL | ||
| Company | Urovant Sciences Ltd | Bioage Labs Inc | Adlai Nortye Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 11.40 | 14.00 | ||
| High | 16.24 | 11.94 | 14.70 | ||
| Low | 16.21 | 11.23 | 13.00 | ||
| Last | 16.24 | 11.72 | 13.28 | ||
| Change | +0.01 | +0.45 | -0.56 | ||
| Percent Change | +0.06% | +3.99% | -4.05% | ||
| Volume | 1,739,000 | 953,500 | 270,000 | ||
| 20-Day Average Volume | 143,510 | 1,357,895 | 222,290 | ||
| Previous | 16.23 | 11.27 | 13.84 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 18.88 | 12.25 | ||
| 20-Day Raw Stochastic | 87.10% | 18.88% | 75.60% | ||
| 20-Day Relative Strength | 65.56 | 35.71 | 56.98 | ||
| Weighted Alpha | +6.45 | +171.12 | +61.42 | ||
| Today's Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 96% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +29.65% since 07/31/26 | +2.15% since 07/31/26 | ||
| Low | 16.20 on 03/24/21 | 9.18 on 08/03/26 | 12.10 on 08/04/26 | ||
| High | 16.25 on 03/25/21 | 11.94 on 08/07/26 | 14.70 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -51.97% since 07/07/26 | +23.31% since 07/07/26 | ||
| Low | 16.10 on 03/02/21 | 8.65 on 07/31/26 | 8.88 on 07/14/26 | ||
| High | 16.26 on 03/19/21 | 25.42 on 07/10/26 | 14.70 on 08/07/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -34.23% since 05/07/26 | -3.07% since 05/07/26 | ||
| Low | 16.03 on 12/30/20 | 8.65 on 07/31/26 | 8.54 on 07/02/26 | ||
| High | 16.26 on 03/19/21 | 25.95 on 07/06/26 | 15.33 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | -43.46% since 02/06/26 | +32.67% since 02/06/26 | ||
| Low | 7.15 on 11/02/20 | 8.65 on 07/31/26 | 6.34 on 03/30/26 | ||
| High | 16.26 on 03/19/21 | 25.95 on 07/06/26 | 17.25 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 537,913 | 531,200 | ||
| Shares Outstanding, K | 32,743 | 45,897 | 40,000 | ||
| Annual Sales, $M | 0 | 9,000,000 | 5,000,000 | ||
| Annual Net Income, $M | -146,750,000 | -80,610,000 | -35,530,000 | ||
| Last Qtr Sales, $M | 0 | 2,770,000 | 0 | ||
| Last Qtr Income, $M | -46,800,000 | -22,250,000 | -63,397,000 | ||
| 60-Month Beta | 2.35 | 0.93 | 1.06 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.58 on 08/05/26 | N/A on 09/29/23 | ||
| Latest Earnings Date | 06/17/21 | 11/05/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||